RainbowChildrenS Med
Ticker > Company >

RainbowChildrenS Med share price

Rainbow Children''s Medicare Ltd.

NSE: RAINBOW BSE: 543524 SECTOR: Hospital & Healthcare Services  1.16 L   165   39

1455.60
-4.65 (-0.32%)
BSE: 15 Sep 04:01 PM

Price Summary

Today's High

₹ 1463.5

Today's Low

₹ 1440.05

52 Week High

₹ 1708.5

52 Week Low

₹ 1205.65

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 14782.95 Cr.

Enterprise Value

₹ 14766.04 Cr.

No. of Shares

10.16 Cr.

P/E

59

P/B

9.61

Face Value

₹ 10

Div. Yield

0.21 %

Book Value (TTM)

₹  151.5

CASH

₹ 16.91 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

49.85 %

EPS (TTM)

₹  24.67

Sales Growth

17.63%

ROE

17.2 %

ROCE

28.54%

Profit Growth

10.56 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year17.63%
3 Year16.3%
5 Year15.91%

Profit Growth

1 Year10.56%
3 Year18.64%
5 Year27.37%

ROE%

1 Year17.2%
3 Year19.8%
5 Year19.35%

ROCE %

1 Year28.54%
3 Year31.69%
5 Year31.49%

Debt/Equity

0

Price to Cash Flow

38.39

Interest Cover Ratio

5.3716

CFO/PAT (5 Yr. Avg.)

1.6029663299901

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 49.85 0.00
Mar 2025 49.85 0.00
Dec 2024 49.85 0.00
Sep 2024 49.85 0.00
Jun 2024 49.88 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 18.6352806826205% for the Past 3 years.
  • The company has shown a good revenue growth of 16.3020676580852% for the Past 3 years.
  • Company has been maintaining healthy ROCE of 31.691% over the past 3 years.
  • Company is virtually debt free.
  • The Company has been maintaining an effective average operating margins of 32.0874849749869% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -131.4114 days.
  • Company has a healthy liquidity position with current ratio of 5.5494.
  • The company has a good cash flow management; CFO/PAT stands at 1.6029663299901.

 Limitations

  • The company is trading at a high PE of 59.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 315.02 403.93 381.57 354 334.75
Total Expenditure 225 260.44 251.41 243.18 235.23
Operating Profit 90.02 143.48 130.16 110.81 99.52
Other Income 11.48 10.72 12.85 13.9 19.29
Interest 17.44 17.39 17.35 17.42 17.39
Depreciation 32.44 33.22 33.54 32.55 32.59
Exceptional Items 0 0 0 0 0
Profit Before Tax 51.63 103.6 92.11 74.75 68.82
Tax 12.9 26.25 25.14 20.21 17.1
Profit After Tax 38.73 77.34 66.98 54.54 51.72
Adjusted EPS (Rs) 3.82 7.62 6.6 5.37 5.09

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 614.45 924.6 1113.99 1236.56 1454.51
Total Expenditure 448.78 625.88 728.96 819.81 975.95
Operating Profit 165.67 298.71 385.03 416.75 478.56
Other Income 11.95 20.82 31.23 36.95 48.95
Interest 43.83 52.8 55.09 59.33 73.68
Depreciation 67.9 76.99 83.71 105.15 131.75
Exceptional Items 0 0 -4.63 0 0
Profit Before Tax 65.89 189.74 272.83 289.22 322.08
Tax 16.48 47.45 66.94 74.33 84.5
Net Profit 49.41 142.29 205.89 214.89 237.59
Adjusted EPS (Rs.) 5.48 15.13 20.28 21.17 23.4

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 54.9 105 101.5 101.5 101.55
Total Reserves 421.03 531.3 986.89 1183.75 1386.99
Borrowings 40.52 27.31 0 0 0
Other N/C liabilities 435.22 493.27 510.38 701.31 695.54
Current liabilities 116.42 116.99 129.06 138.51 141.55
Total Liabilities 1068.09 1273.86 1727.83 2125.07 2325.63
Assets
Net Block 722.18 812.86 891.48 1218.7 1367.76
Capital WIP 28.68 4.6 20.9 13.82 27.67
Intangible WIP 0.09 1.16 1.91 6.09 0.69
Investments 29.27 20.17 46.55 46.55 46.55
Loans & Advances 55.43 112.01 82.07 227.67 83.61
Other N/C Assets 15.09 43.19 218.63 17.94 13.85
Current Assets 217.35 279.86 466.31 594.3 785.5
Total Assets 1068.09 1273.86 1727.83 2125.07 2325.63
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 65.89 189.74 272.83 289.22 322.08
Adjustment 100.25 109.51 115.81 130.08 152.04
Changes in Assets & Liabilities 1.92 -23.17 5.23 -26.81 -5.03
Tax Paid -26.51 -62.02 -78.32 -86.07 -84.04
Operating Cash Flow 141.56 214.06 315.56 306.42 385.05
Investing Cash Flow -86.79 -169.2 -460.28 -213.73 -262.69
Financing Cash Flow -56.43 -41.13 147.68 -97 -112.95
Net Cash Flow -1.67 3.73 2.96 -4.31 9.4

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 49.88 49.85 49.85 49.85 49.85
adarsh kancharla 6.02 6.02 6.02 6.02 6.02
chirla dinesh kumar padma... 6.54 6.53 6.53 6.53 6.53
chirla padmarao dinesh ku... - - - 1.02 1.02
ramadhara naidu k 0.06 0.06 0.06 0.06 0.06
ramesh kancharla 31.05 31.04 31.04 31.04 31.04
ramesh kancharla (kanchar... - - - 5.13 5.13
srinivas talasila 0.06 0.06 0.06 0.06 0.06
chirla dineshkumar padma ... 1.02 1.02 1.02 - -
ramesh kancharla (kancha... 5.13 5.13 5.13 - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 50.12 50.15 50.15 50.15 50.15
abu dhabi investment auth... 1.96 1.90 1.93 2.08 2.02
ashoka whiteoak icav - as... - - - 1.31 1.25
axis mutual fund trustee ... - 1.79 1.97 - 2.02
devineni nagalakshmi 1.22 - 1.22 1.18 1.18
dsp aggressive hybrid fun... - - - 4.27 4.37
franklin templeton invest... 1.57 - - 2.24 2.24
hdfc life insurance compa... 1.80 1.80 1.52 1.48 1.49
kuwait investment authori... - - - - 1.02
nippon life india trustee... - - - 1.08 1.08
podduturu preetham kumar 1.16 1.14 1.11 1.10 1.07
axis mutual fund trustee ... - - - 2.02 -
sbi nifty smallcap 250 in... - 1.30 1.34 1.32 -
amansa holdings private l... 2.87 2.86 2.84 - -
ashoka whiteoak icav - as... 1.52 1.53 1.52 - -
dsp equity & bond fund 2.73 3.02 2.97 - -
franklin templeton invest... - 2.24 2.24 - -
nippon life india trustee... 1.58 1.05 1.07 - -
stichting depositary apg ... 1.52 1.36 1.01 - -
nagalakshmi devineni - 1.22 - - -
axis mutual fund trustee ... 1.93 - - - -
hsbc consumption fund 1.01 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2025
Annual Report 2024
Annual Report 2023
Annual Report 2022

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit ICRA
Credit ICRA
TYPE AGENCY Link
TYPE AGENCY Link
Research HDFC Securities

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY24
Concall Q4FY22
Concall Q3FY25
Concall Q3FY24
Concall Q2FY24
Concall Q1FY25
Concall Q1FY23
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY24
Presentation Q4FY22
Presentation Q3FY24

Company News

Rainbow Children's Medicare commences 100-bed greenfield hospital in Andhra Pradesh 11 Sep, 10:42 AM Rainbow Children's Medicare to acquire 76% stake in Pratiksha Hospital 12 Aug, 10:08 AM RainbowChildrenS Med - Quaterly Results 26 Jul, 4:31 PM RainbowChildrenS Med - Quaterly Results 26 Jul, 4:31 PM RainbowChildrenS Med - Quaterly Results 26 Jul, 4:31 PM Rainbow Children's Medicare acquires 76% equity share capital of Prashanthi Medicare 2 Jul, 12:59 PM Rainbow Children’s Medicare signs agreement to acquire majority stake in Prashanthi Medicare 30 Jun, 3:12 PM RainbowChildrenS Med - Quaterly Results 24 May, 6:49 PM RainbowChildrenS Med - Quaterly Results 24 May, 6:49 PM Rainbow Children’s Medicare informs about newspaper advertisement 4 Mar, 3:34 PM Rainbow Children's Medicare receives approvals from HSVP for hospitals at Gurugram 3 Mar, 3:14 PM Rainbow Children's Medicare reports 10% rise in Q3 consolidated net profit 10 Feb, 10:58 AM RainbowChildrenS Med - Quaterly Results 9 Feb, 5:46 PM RainbowChildrenS Med - Quaterly Results 9 Feb, 5:46 PM Rainbow Children’s Medicare informs about newspaper advertisement 29 Oct, 5:10 PM RainbowChildrenS Med - Quaterly Results 27 Oct, 6:20 PM RainbowChildrenS Med - Quaterly Results 27 Oct, 6:20 PM RainbowChildrenS Med - Quaterly Results 13 Aug, 4:08 PM RainbowChildrenS Med - Quaterly Results 13 Aug, 4:08 PM RainbowChildrenS Med - Quaterly Results 13 Aug, 4:08 PM Rainbow Children's Medicare informs about annual secretarial compliance report 25 May, 12:21 PM RainbowChildrenS Med - Quaterly Results 19 May, 6:19 PM RainbowChildrenS Med - Quaterly Results 19 May, 6:19 PM Rainbow Children’s Medicare adds 50-bed additional block in Hydernagar Hospital 8 Mar, 3:10 PM Rainbow Children’s Medicare launches 80 beds spoke hospital in Chennai 1 Mar, 6:40 PM Rainbow Children's Medicare submits analyst meet intimation 24 Feb, 12:34 PM Rainbow Children’s Medicare inaugurates new hospital in Karnataka 25 Jan, 2:07 PM RainbowChildrenS Med - Quaterly Results 24 Jan, 4:06 PM RainbowChildrenS Med - Quaterly Results 24 Jan, 4:06 PM RainbowChildrenS Med - Quaterly Results 24 Jan, 4:06 PM Rainbow Children's Medicare inks pact with Ministry of Health, Zanzibar 16 Jan, 11:30 AM Rainbow Children’s Medicare commences new hospital at Hyderabad 4 Jan, 4:19 PM Rainbow Children's Medicare informs about change in directorate 30 Oct, 5:22 PM Rainbow Children's Medicare informs about outcome of board meeting 30 Oct, 5:11 PM RainbowChildrenS Med - Quaterly Results 30 Oct, 5:00 PM RainbowChildrenS Med - Quaterly Results 30 Oct, 5:00 PM RainbowChildrenS Med - Quaterly Results 30 Oct, 5:00 PM Rainbow Children’s Medicare informs about transcript of investor call 16 Aug, 2:01 PM RainbowChildrenS Med - Quaterly Results 7 Aug, 3:48 AM RainbowChildrenS Med - Quaterly Results 7 Aug, 3:48 AM RainbowChildrenS Med - Quaterly Results 7 Aug, 3:48 AM Rainbow Children's Medicare submits analyst meet intimation 2 Aug, 12:23 PM Rainbow Children's Medicare informs about analyst meet 8 Jun, 4:52 PM Rainbow Children's Medicare informs about press release 8 Jun, 3:08 PM RainbowChildrenS Med - Quaterly Results 14 May, 7:06 PM RainbowChildrenS Med - Quaterly Results 14 May, 7:06 PM Rainbow Children's Medicare submits analyst meet intimation 13 Mar, 11:53 AM Rainbow Children's Medicare informs about updates 1 Mar, 4:49 PM Rainbow Children’s Medicare inaugurates new hospital in Hyderabad 1 Mar, 4:23 PM Rainbow Children's Medicare informs about earnings call transcript 18 Feb, 11:02 AM

RainbowChildrenS Med Stock Price Analysis and Quick Research Report. Is RainbowChildrenS Med an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse RainbowChildrenS Med. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). RainbowChildrenS Med has a PE ratio of 59.0357148647115 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. RainbowChildrenS Med has ROA of 10.6763% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. RainbowChildrenS Med has a Current ratio of 5.5494.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. RainbowChildrenS Med has a ROE of 17.201%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. RainbowChildrenS Med has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: RainbowChildrenS Med has reported revenue growth of 17.6251% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of RainbowChildrenS Med for the current financial year is 32.9017323395487%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for RainbowChildrenS Med is Rs 3 and the yield is 0.2061%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of RainbowChildrenS Med is Rs 24.6732. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of RainbowChildrenS Med in Ticker for free. Also, one can get the intrinsic value of RainbowChildrenS Med by using Valuation Calculators, which are available with a Finology ONE subscription. 

RainbowChildrenS Med FAQs

Q1. What is RainbowChildrenS Med share price today?
Ans: The current share price of RainbowChildrenS Med is Rs 1456.6.

Q2. What is the market capitalisation of RainbowChildrenS Med?
Ans: RainbowChildrenS Med has a market capitalisation of Rs 14793.10666296 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of RainbowChildrenS Med?
Ans: The PE ratio of RainbowChildrenS Med is 59.0357148647115 and the P/B ratio of RainbowChildrenS Med is 9.61474357493408, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of RainbowChildrenS Med share?
Ans: The 52-week high share price of RainbowChildrenS Med is Rs 1709.6, and the 52-week low share price of RainbowChildrenS Med is Rs 1218.

Q5. Does RainbowChildrenS Med pay dividends?
Ans: Currently, RainbowChildrenS Med pays dividends. Dividend yield of RainbowChildrenS Med is around 0.2061%.

Q6. What are the face value and book value of RainbowChildrenS Med shares?
Ans: The face value of RainbowChildrenS Med shares is Rs 10, while the book value per share of RainbowChildrenS Med is around Rs 151.4965. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of RainbowChildrenS Med?
Ans: RainbowChildrenS Med has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of RainbowChildrenS Med?
Ans: The ROE of RainbowChildrenS Med is 17.201% and ROCE of RainbowChildrenS Med is 28.5356%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is RainbowChildrenS Med a good buy for the long term?
Ans: The RainbowChildrenS Med long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is RainbowChildrenS Med undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the RainbowChildrenS Med appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check RainbowChildrenS Med’s financials?
Ans: You can review RainbowChildrenS Med’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about RainbowChildrenS Med

Rainbow Children's Medicare Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Rainbow Children's Medicare Ltd. is a leading healthcare provider focused on delivering specialized pediatric care. The company operates a network of hospitals and clinics across the country, serving children from infancy to adolescence. With a strong emphasis on quality, Rainbow Children's Medicare Ltd. aims to provide comprehensive medical services that cater to the unique needs of young patients.

Rainbow Children's Medicare Ltd. - Share Price

Stay informed about the latest developments in Rainbow Children's Medicare Ltd.'s stock price. Our website provides real-time updates on the company's share price, allowing investors to track its performance in the market. Access historical data and interactive charts to gain insight into stock trends and make informed investment decisions.

Rainbow Children's Medicare Ltd. - Balance Sheet

Get access to Rainbow Children's Medicare Ltd.'s latest balance sheet on our website. Our pre-built screening tools enable long-term stock investors to analyze the company's financial position. Understand the composition of its assets, liabilities, and shareholders' equity, and evaluate the company's ability to meet its financial obligations. Utilize our premium features, such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis, to calculate fair value and make informed investment decisions.

Rainbow Children's Medicare Ltd. - Annual Report

The annual report of Rainbow Children's Medicare Ltd. is available for download on our website. Gain deep insights into the company's performance over the past year, including its financial results, business strategies, and future prospects. Analyze crucial metrics, such as revenue growth, profitability, and operational efficiency, to assess the company's long-term viability.

Rainbow Children's Medicare Ltd. - Dividend

Stay updated on Rainbow Children's Medicare Ltd.'s dividend announcements. Our website provides detailed information about the company's dividend policy, dividend history, and dividend yield. Long-term stock investors can evaluate the company's dividend-paying track record and assess its ability to generate consistent returns.

Rainbow Children's Medicare Ltd. - Quarterly Result

Access Rainbow Children's Medicare Ltd.'s quarterly results on our website. Stay abreast of the company's financial performance across different quarters, including revenue, earnings, and key operational metrics. Further enhance your analysis with our premium features, such as fair value calculation tools, to make well-informed investment decisions.

Rainbow Children's Medicare Ltd. - Stock Price

Track Rainbow Children's Medicare Ltd.'s stock price trends on our website. Our platform provides historical data and interactive price charts, allowing investors to monitor the stock's performance over time. Evaluate market sentiment and identify potential buying or selling opportunities based on informed analysis.

Rainbow Children's Medicare Ltd. - Price Chart

Visualize Rainbow Children's Medicare Ltd.'s stock price movements using our intuitive price chart. Identify key patterns, trends, and support/resistance levels to enhance your technical analysis. Stay informed about market sentiment and adjust your investment strategy accordingly.

Rainbow Children's Medicare Ltd. - News and Updates

Stay up to date with the latest news and updates related to Rainbow Children's Medicare Ltd. on our website. Access comprehensive coverage of company announcements, regulatory filings, and industry developments. Stay informed about major events that may impact the company's stock price and make informed investment decisions.

Rainbow Children's Medicare Ltd. - Concall Transcripts

Access Rainbow Children's Medicare Ltd.'s concall transcripts on our website. Gain insights into the company's management discussions, future plans, and market outlook. Analyze the company's performance in the context of industry trends and investor sentiment to make informed investment decisions.

Rainbow Children's Medicare Ltd. - Investor Presentations

Download Rainbow Children's Medicare Ltd.'s investor presentations from our website. Stay informed about the company's strategic initiatives, financial performance, and growth potential. Evaluate information shared in these presentations to gain a comprehensive understanding of the company's prospects.

Rainbow Children's Medicare Ltd. - Promoters

Gain insights into Rainbow Children's Medicare Ltd.'s promoters, who play a crucial role in the company's management and growth. Our website provides information about the promoters' background, their stake in the company, and their involvement in key decision-making processes. Evaluate the credibility and expertise of the promoters to assess the company's long-term potential.

Rainbow Children's Medicare Ltd. - Shareholders

Understand Rainbow Children's Medicare Ltd.'s shareholder base, which plays a significant role in shaping the company's governance and strategic direction. Our website provides information on the major shareholders and institutional investors associated with the company. Analyze the composition of the shareholder base and their level of involvement to assess the company's stability and long-term growth prospects.

At [your website], you can access a wealth of information and tools to conduct a comprehensive analysis of Rainbow Children's Medicare Ltd. Make use of our pre-built screening tools, downloadable annual reports, concall transcripts, investor presentations, credit ratings, and research reports to equip yourself with the necessary insights for making sound investment decisions.

Note: This content is written for website purposes and may need to be adjusted for formatting on a webpage. 

Rainbow Children's Medicare Balance Sheet Analysis

Rainbow Children's Medicare Share Capital Stability

The share capital of Rainbow Children's Medicare remained relatively stable over five years, showing minor adjustments from Rs 54.91 Cr in March 2020 to Rs 101.50 Cr by March 2024. This suggests a conservative approach towards financing through equity.

Rainbow Children's Medicare Reserves Growth

Significant growth is observed in the company's total reserves, increasing from Rs 370.71 Cr in March 2020 to Rs 1,183.75 Cr in March 2024, indicating robust internal accruals and reinvestment strategy.

Rainbow Children's Medicare Debt Reduction

The company demonstrated effective debt management by reducing its borrowings from Rs 45.81 Cr in March 2020 to zero by March 2023. This reflects a strong financial position and a focus on sustaining operations through internal finances.

Rainbow Children's Medicare Asset Expansion

Total assets of Rainbow Children's Medicare grew impressively, from Rs 1,091.31 Cr in March 2020 to Rs 2,125.07 Cr in March 2024. This growth is supported mainly through the increase in the net block and current assets, suggesting capital investment and liquidity improvements.

This data is an analysis of the Standalone Balance Sheet of the company.

Rainbow Children's Medicare is part of a sector that often finds its dynamics influenced by regulatory changes, making it a key point of interest in market analysis.

Read More
X